# Alivus Life Sciences (NSE: ALIVUS) — share price, financials and shareholding

Source: https://companystockprice.com/stocks/alivus-life-sciences

## Key facts
- Company: Alivus Life Sciences Limited
- NSE symbol: ALIVUS (BSE code 543322)
- ISIN: INE03Q201024
- Last close: ₹1,380.00 (+0.05%)

## About
Alivus Life Sciences Limited develops and manufactures active pharmaceutical ingredients in India, the United States, Europe, Japan, Russia, Brazil, South Korea, Taiwan, Canada, China, and Australia. It offers various APIs, such as amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, solifenacin, atovaquone, etoricoxib, dapagliflozin, and sitagliptin for therapeutic areas, including cardiovascular, central nervous system, diabetes, oncology, urology, and pain management, as well as anti-fungal, anti-histaminic, anti-acne, anti-emetics immunomodulators, anti-ulceratives, immunosuppressant, respiratory agent, ophthalmologic agent, anti-spasmodic, and urology. The company also provides contract development and manufacturing comprising process development, analytical development and support, and API and intermediate manufacturing; and research and development, intellectual property, quality and compliance, customer experience, regulatory support. In addition, it exports its products. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was founded in 2001 and is based in Mumbai, India. Alivus Life Sciences Limited operates as a subsidiary of Nirma Limited.

## FAQ
**What is the Alivus Life Sciences company stock price today?**
Alivus Life Sciences (ALIVUS) last traded at ₹1,380.00 on the NSE, up 0.05% from the previous close.

**What is the market cap of Alivus Life Sciences?**
Alivus Life Sciences has a market capitalisation of about ₹16,942 crore.

**What is the P/E ratio of Alivus Life Sciences?**
Alivus Life Sciences trades at a price-to-earnings ratio of 28.1 based on trailing twelve-month earnings.

**What is the 52-week high and low of Alivus Life Sciences?**
The 52-week high of Alivus Life Sciences shares is ₹1,493.80 and the 52-week low is ₹819.00.

**What is the NSE symbol of Alivus Life Sciences?**
Alivus Life Sciences trades on the National Stock Exchange of India under the symbol ALIVUS, and on the BSE under scrip code 543322. Its ISIN is INE03Q201024.

**When was Alivus Life Sciences listed on the NSE?**
Alivus Life Sciences was listed on the NSE on 6 August 2021.

---
Prices may be delayed. Informational only, not investment advice. Methodology: https://companystockprice.com/methodology